The normothermic machine perfusion market is anticipated to continue its rapid expansion in the future, with a projected growth to $2.73 billion in 2029 at a CAGR of 16.2%.

Since gaining regulatory approval in 2018 following an Oxford-led clinical study published as a cover story in Nature , OrganOx's automated normothermic machine perfusion technology has been used to ...

The collaboration combines the OrganOx metra normothermic machine perfusion (NMP) platform with ProCure’s surgical, perfusion, preservation and logistics services.

Advancements in heart transplant technology, focusing on machine perfusion's role in extending the time window for organ transport.

The inception of machine perfusion, in which a device pumps a blood-like solution through the donor heart during transport, has significantly extended that window.

Top Trends in the Organ Preservation Market One of the most noteworthy trends in the organ preservation market is the shift toward machine perfusion technologies, both hypothermic and normothermic.

Organ perfusion is only available in select cases, and your transplant surgeon is best qualified to make the final decision to employ organ machine perfusion.

The partnership aims to improve the recovery and assessment of donor livers for transplantation by leveraging OrganOx’s normothermic machine perfusion (NMP) technology and ProCure’s solutions.

Post this The KidneyVault Portable Renal Perfusion System received FDA-clearance in October 2024 and is designed for seamless, end-to-end hypothermic perfusion.

“Hypothermic perfusion increases the availability of high-quality donor kidneys nationwide” Post this The KidneyVault Portable Renal Perfusion System received FDA clearance in October of 2024.

Bridge to Life Ltd is a market leader in organ preservation solutions, offering premier products such as Belzer UW®, EasiSlush® and the VitaSmart 2 Machine Perfusion System.